ARCHITECT C16000 SYSTEM
Report
- Report Number
- 1628664-2018-01848
- Event Type
- Malfunction
- Date Received
- September 7, 2018
- Date of Event
- June 7, 2018
- Report Date
- September 7, 2018
- Manufacturer
- ABBOTT MANUFACTURING INC
- Product Code
- JJE
- UDI-DI
- 00380740005924
- PMA / PMN Number
- EXEMPT
- Removal / Correction Number
- 1628664-07/17/18-001-C
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- EI
- Reporter Occupation
- OTHER
Narratives
COMPLETE INFORMATION FOR SECTION A PATIENT INFORMATION. PATIENT IDENTIFIER- MULTIPLE = (B)(6). A PRODUCT CORRECTION LETTER WAS ISSUED TO ALL ARCHITECT CLINICAL CHEMISTRY CUSTOMERS NOTIFYING THEM TO ADHERE TO THE LABELING INSTRUCTIONS LISTED IN THE ARCHITECT OPERATIONS MANUAL, SECTION 10, TO RESOLVE ERROR CODES 3580 TO 3585 OR 5381 BEFORE TRANSITIONING THE ARCHITECT TO THE RUNNING STATUS. THE PRODUCT CORRECTION LETTER PROVIDES GUIDANCE ON HOW THE CUSTOMER CAN ENSURE THE PRESSURE MONITORING SYSTEM IS FUNCTIONING AND ALSO RECOMMENDS FOLLOWING THE ARCHITECT SYSTEMS OPERATIONS MANUAL AND THE ASSAY-SPECIFIC DOCUMENTATION TO ENSURE ALL SAMPLES AND REAGENTS MEET DESCRIBED REQUIREMENTS BEFORE BEING PLACED ON THE ARCHITECT. THE INVESTIGATION FOUND THAT WHEN THE PRESSURE MONITOR BOARD COMMUNICATION ON THE ARCHITECT CLINICAL CHEMISTRY ANALYZER IS NOT SUCCESSFULLY ESTABLISHED DURING INITIAL INSTRUMENT BOOT UP, AND THE FOLLOWING ERROR CODES 3580 TO 3585 OR 5381 ARE NOT RESOLVED BY THE USER PRIOR TO TRANSITIONING THE ARCHITECT TO THE RUNNING STATUS, THERE IS THE POTENTIAL TO GENERATE INCORRECT RESULTS AS THE PRESSURE MONITORING SYSTEM IS INACTIVE. THE ARCHITECT SYSTEM SOFTWARE WILL BE UPDATED IN A FUTURE VERSION TO PREVENT THE ARCHITECT ANALYZER FROM TRANSITIONING TO THE RUNNING STATUS WHEN THE PRESSURE MONITORING SYSTEM IS IN AN ERROR STATE.
THE CUSTOMER REPORTED INCONSISTENT/FALSELY ELEVATED SODIUM RESULTS ON THE ARCHITECT C16000 ANALYZER. THE FOLLOWING RESULTS WERE PROVIDED: ON 07 JUN 2018 (B)(6): 142, 136, 143 AND 144 MMOL/L; ON 12 JUN 2018 (B)(6): 139, 143, 142, 142 MMOL/L; (B)(6): 143, 138, 136 AND 137 MMOL/L; AND ON 13 JUN 2018 (B)(6): 139, 134, 139, 138 MMOL/L. NO ADVERSE IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 697820 | ARCHITECT C16000 SYSTEM | AUTOMATED CHEMISTRY ANALYZER | JJE | ABBOTT MANUFACTURING INC | 00380740005924 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |